Exchange: NASDAQ·Updated 07:30 PM EDT
CCCC logo

CCCC C4 Therapeutics Inc

$3.76
$0.02
(0.54%)
Today
Closed $3.76
$0.0368
(0.98%)
After Hours
Reported EarningsAug 11
Mkt Cap$462.57M
Vol2.36M

About CCCC

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in 2015 and is headquartered in Watertown, MA.
50

Neutral Sentiment

How do you feel about CCCC?

Advertisement|Remove ads.